🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark Farha

ORCID: 0000-0002-3511-2630

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Characterization of the Tumor Immune Microenvironment Identifies M0 Macrophage-Enriched Cluster as a Poor Prognostic Factor in Hepatocellular Carcinoma”.

Characterization of the Tumor Immune Microenvironment Identifies M0 Macrophage-Enriched Cluster as a Poor Prognostic Factor in Hepatocellular Carcinoma

JCO Clinical Cancer Informatics(2020)10.1200/cci.20.00077

N/A

0DataRank · unranked

56 citations

Neil Jairath, Theodore S. Lawrence, Issam El Naqa, Mark Farha

Prognostic value and therapeutic implications of an integrative molecular subtype and immune content classifier in localized muscle-invasive bladder cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.530

N/A

0DataRank · unranked

1 citations

Brittney Cotta, Randy Vince, Srinivas Nallandhighal, Samuel D. Kaffenberger, Philip Palmbos +6 more

Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype

Cancers(2023)10.3390/cancers15235530

N/A

0DataRank · unranked

13 citations

Srinivas Nallandhighal, Randy Vince, Brittney Cotta, Judith Stangl‐Kremser, Daniel Triner +7 more